J&J’s BCMA bispecific Tecvayli wins FDA approval in multiple myeloma—but as a late-line therapy aliu Tue, 10/25/2022 – 17:10 More: J&J's BCMA bispecific Tecvayli wins FDA approval in multiple myeloma—but as a late-line therapy Source: fierce
read moreNovartis CEO says rising energy costs are ‘not a topic of concern’ for generics unit Sandoz kdunleavy Tue, 10/25/2022 – 15:36 More: Novartis CEO says rising energy costs are 'not a topic of concern' for generics unit Sandoz Source: fierce
read moreGSK shuffles execs and streamlines businesses as vaccines chief Connor heads for the exit fkansteiner Tue, 10/25/2022 – 14:27 More: GSK shuffles execs and streamlines businesses as vaccines chief Connor heads for the exit Source: fierce
read moreMayo Clinic-backed CDMO Nucleus RadioPharma emerges on a mission to overhaul radiotherapy access fkansteiner Tue, 10/25/2022 – 12:52 More: Mayo Clinic-backed CDMO Nucleus RadioPharma emerges on a mission to overhaul radiotherapy access Source: fierce
read moreMerck fined $38M in Spain for hindering generic competition for NuvaRing kdunleavy Tue, 10/25/2022 – 11:18 More: Merck fined M in Spain for hindering generic competition for NuvaRing Source: fierce
read moreMillions will be invited to join the programme to ‘prevent, detect and treat’ diseases More: UK’s largest health research programme launched Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals